For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250919:nRSS0374Aa&default-theme=true
RNS Number : 0374A Wellnex Life Limited 19 September 2025
ASX/AIM
Announcement
19 September 2025
Wellnex Life Limited (ASX/AIM: WNX)
Appointment of Non-executive Chair
Wellnex Life Limited ("Wellnex" or the "Company") (ASX/AIM: WNX) is pleased to
announce that, further to the Company's announcement on 9 September 2025 and
the conclusion of customary due diligence by the Company's Nominated Advisor
on AIM, Ash Vesali has been appointed to the Board as Non-Executive Chairman
with immediate effect.
Additional Information:
Save for the information set out above and below, there are no further
disclosures to be made in accordance with Rule 17 and Schedule Two, paragraph
(g), of the AIM Rules in respect of the appointment of Ash Vesali.
Arash Vesali (aged 49) does not currently hold, or has held in the last 5
years, any directorships or partnerships.
This ASX/AIM announcement has been authorised by the Board of Wellnex Life
Limited (ASX/AIM:WNX).
For further information, please contact:
Wellnex Life Limited (ASX:WNX)
Reach Markets
Zack Bozinovski
T: 1300 805 795
Chief Executive Officer & Managing
Director E: IR@reachmarkets.com.au
(mailto:IR@reachmarkets.com.au)
P: +61 3 8399 9419
E: zack.b@wellnexlife.com.au (mailto:zack.b@wellnexlife.com.au)
UK Investors
Strand Hanson (Financial & Nominated Advisor)
James Harris / Richard Johnson
Tel: +44 (0) 20 7409 3494
Orana Corporate LLP (Joint
Broker)
swykeham@oranacorp.com (mailto:swykeham@oranacorp.com)
Sebastian Wykeham
S.P. Angel Corporate Finance LLP (Joint Broker)
Tel: +44 (0)20 3470 0470
David Hignell / Vadim Alexandre
To learn more, please visit: www.WellnexLife.com.au/
(http://www.wellnexlife.com.au/)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOAEKLBFEKLLBBZ